Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB26FQAWQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,493
Award facts
- Contract value 100% obligated
- $11,492.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,492.54 to AmerisourceBergen Drug Corp for the supply of Wegovy 2.4 mg/0.75 mL pen (0.75 mL) with an ultimate completion date of October 31, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
The delivery order reflects ongoing federal procurement of pharmaceutical products to support military healthcare systems. Wegovy, a GLP-1 receptor agonist medication, represents the type of specialty pharmaceutical that the contractor regularly supplies through its extensive federal contract portfolio covering diabetes medications, neurological treatments, pain management pharmaceuticals, and other critical medical commodities. AmerisourceBergen's substantial indefinite delivery contract enables flexible procurement across multiple therapeutic domains to serve the Defense Health Agency and other government healthcare systems globally, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB26FQAWQ?
SPE2DB26FQAWQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FQAWQ worth?
The government has obligated $11,493 on SPE2DB26FQAWQ.
Is contract SPE2DB26FQAWQ an order under another contract?
Yes. SPE2DB26FQAWQ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB26FQAWQ competed?
The extent of competition for SPE2DB26FQAWQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award